Medkart Pharmacy is a technology company.
Medkart Pharmacy has raised $5.0M across 1 funding round.
Medkart Pharmacy has raised $5.0M in total across 1 funding round.
Medkart Pharmacy is a health tech startup founded in 2014 in Ahmedabad, India, that operates a chain of retail pharmacies and an online platform focused on generic medicines, branded drugs, over-the-counter products, and healthcare services like lab tests.[1][2][3] It serves patients seeking affordable medication alternatives, solving the problem of high branded drug costs by educating users on generics from WHO-GMP certified manufacturers, enabling price comparisons, and delivering savings—claiming over ₹600 crore saved for 10 lakh loyal customers across 35,000+ pincodes with 75 lakh+ orders fulfilled.[3][4] With 100+ stores mainly in Gujarat and Rajasthan, Series A funding of $5.4M raised four years ago, and 242 employees, Medkart shows steady growth in India's digital health space, including India's first dedicated app for generic medicine purchases launched in 2022.[1][2][4]
Medkart Pharmacy was founded in 2014 by Ankur Agarwal and co-founder Parasharan Chari in Ahmedabad, driven by a mission to educate Indians about generic medicines and bridge the massive price gap with branded versions, countering myths that generics are inferior.[2][3][4] Recognizing limited awareness and over-reliance on expensive brands, the team started as a pharmacy chain emphasizing transparency, affordability, and quality from WHO-GMP certified sources, evolving from physical stores to an online portal and Android app in 2022 for searching molecules, comparing prices, and informed buying.[1][3][4] Early traction built through customer trust, expanding to 100+ outlets and nationwide delivery, fueled by pivotal Supreme Court comments on mandating generics for affordability.[4]
Medkart rides India's digital health boom, where online pharmacies and generics adoption are surging amid rising healthcare costs and government pushes for affordability, like Supreme Court suggestions to prioritize generics.[1][4] Timing aligns with post-pandemic e-pharma growth and smartphone penetration enabling apps for price discovery, positioning Medkart against competitors in a market favoring cost-effective, tech-enabled alternatives to branded drugs.[1] It influences the ecosystem by normalizing patient-driven generic choices—a practice common in developed markets—driving awareness, competition on quality/pricing, and broader access in underserved pincodes, while fitting into expert collections like Digital Health.[1][6]
Medkart is poised for expansion by leveraging its generics expertise into more telehealth integrations, AI-driven recommendations, or partnerships with insurers/hospitals amid India's generics push. Trends like regulatory support for generics, e-pharma consolidation, and rising chronic disease prevalence will accelerate growth, potentially boosting store counts and funding for pan-India dominance. Its influence may evolve from educator to market leader, reshaping how patients access affordable care and challenging branded dominance—ultimating its 2014 vision of a healthier, empowered India.
Medkart Pharmacy has raised $5.0M in total across 1 funding round.
Medkart Pharmacy's investors include Alkemi Growth Capital.
Medkart Pharmacy has raised $5.0M across 1 funding round. Most recently, it raised $5.0M Series A in November 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2021 | $5.0M Series A | Alkemi Growth Capital |